-
Liraglutide APILiraglutide API is a high-end active pharmaceutical ingredient (API) of the GLP-1 receptor agonist class. It is the core raw material for blood glucose control in type 2 diabetes and chronic weightread more
-
Terlipressin FDATerlipressin API (Terlipressin Active Pharmaceutical Ingredient) is a synthetic long-acting vasopressin analog with the chemical identifier CAS 14636-12-5. It is a core raw material for critical careread more
-
Carbetocin APICarbetocin (CAS 37025-55-1) is a long-acting synthetic oxytocin analog and a classic pharmaceutical raw material in polypeptide synthesis. With years of clinical validation and process optimization,read more
-
Cagrilintide and SemaglutideCagrilintide (CAS 1415456-99-3) is a long‑chain acylated amylin analogue and a dual agonist of amylin and calcitonin receptors. CAS Number 1415456-99-3 Formularead more
-
Atosiban APIAtosiban (CAS 90779-69-4) is a high-purity Atosiban API and polypeptide raw material for pharmaceutical use, acting as an effective oxytocin receptor antagonist for anti-preterm birth drugread more
-
Tamoxifen Citrate PowderTamoxifen Citrate Powder (CAS 54965-24-1) is one of the most widely used and longest-established anti-estrogen antitumor raw materials in global clinical practice, especially effective on theread more
-
Epalrestat FDAEpalrestat CAS 82159-09-9 is the only globally marketed aldose reductase inhibitor API, first-line treatment for diabetic peripheral neuropathy. It blocks the polyol pathway, reduces sorbitolread more
-
Finerenone APIFinerenone API (CAS 1050477-31-0) is a new-generation nonsteroidal cardiorenal protective drug substance with highly selective mineralocorticoid receptor antagonism, providing core pharmaceutical rawread more
-
Estradiol APIOur estradiol API series consists of key steroidal estrogen raw materials, including natural endogenous estradiol API (CAS 50-28-2), synthetic potent Estradiol valerate (CAS 979-32-8), andread more
-
Retatrutide APIRetatrutide API (CAS 2381089-83-2), a first-in-class peptide GLP-1/GIP/GCG triple receptor agonist developed by Eli Lilly, is a breakthrough API for the treatment of type 2 diabetes and obesity.read more
-
Orforglipron APIOrforglipron API (CAS 2212020-52-3) is a pioneering oral non-peptide small-molecule GLP-1 receptor agonist developed by Eli Lilly. As a breakthrough Orforglipron raw material (API) for type 2read more
WebThe liraglutide drug substance manufacturing process has adequately been described and a flow chart has been provided. Briefly, it consists of the following main steps: fermentation of yeast...
WebLiraglutide is a once-daily GLP-1 derivative for the treatment of type 2 diabetes. GLP-1, in its natural form, is short-lived in the body (the half-life after subcutaneous injection is...
WebLiraglutide precursor is produced using recombinant DNA technology in yeast (Saccharomyces cerevisiae). The chemical name of liraglutide is glycine,......
WebView All Manufacturers & Suppliers of Liraglutide API with Drug Master Files (DMF), CEP/COS, Japanese DMFs, Written Confirmation (WC) details listed on...
WebLiraglutide, is a 31-amino acid peptide analogue of the human glucagon-like peptide-1 (GLP-1) and acts as a GLP-1 receptor agonist, differing from the human glucagon-like peptide ... Albericio F....
WebA Liraglutide DMF ( Drug Master File) is a document detailing the whole manufacturing process of Liraglutide active pharmaceutical ingredient (API) in detail. Different forms of Liraglutide DMFs...
